Multiple sclerosis (MS)

MS and iboga. What the science suggests, and how we can help.

Whether you live with MS or you are reading this for a partner, a mother or a father, you are welcome here. In animal research, iboga's main alkaloid touches some of the signals the brain uses to repair the coating of its nerves. It is early theory, not a cure, and it never replaces your MS treatment. What we offer is a traditional Missoko Bwiti ceremony, a physician on site day and night, and a medical team that reviews every file and plans the retreat around your MS.

  • 2 peoplethe only published human report of ibogaine in MS, without a control group
  • 24/7physician on site
  • Stable, early MSstrongly recommended, every file reviewed by our medical team
Cover of the free guide Room to Breathe

Free guide · PDF

Room to Breathe

Multiple sclerosis: the ceremony, the numbers, the research and how to prepare.

Scroll to explore

How we can help

A careful ceremony, built around your MS

MS is more than a scan. It touches walking, energy, sensation, the bladder and mood, and it brings an uncertain future into everyday plans. A retreat with us works on all of it at once: the medicine and the ceremony for the mind and the spirit, a medical team for the body, and three months of follow-up so that what opens during the stay has time to settle into daily life.

We will not promise to cure MS, repair myelin, or stop it progressing, and no one honestly can. Iboga does not replace your disease-modifying treatment, your neurologist or your therapy. In the tradition you come without expectations; what we can promise is careful preparation, a team at your side all night, and honesty about what is known.

The mechanism

How iboga's alkaloids may act on nerves in MS

In the brain and spinal cord, nerve fibres are wrapped in myelin, a fatty coating made by cells called oligodendrocytes. It lets signals jump quickly along the nerve. In MS, immune cells cross from the blood into the brain and spinal cord and attack the coating, leaving inflamed patches called lesions. Where the coating is stripped, signals slow down or fail. The brain can rebuild myelin with its own repair cells, but repair becomes less efficient with time and fails in many long-standing lesions.

Iboga's main alkaloid, ibogaine, is turned by the liver into noribogaine, which lasts much longer in the body. In rats, ibogaine raised the brain's messages for growth factors, and in mice one of those growth factors, BDNF, was needed to rebuild myelin. Noribogaine acts on the kappa opioid receptor, and other drugs that act on that receptor helped myelin repair in mice. None of this has been tested with iboga in MS. The animation shows the idea, step by step.

The alkaloids in iboga root bark

  • Ibogaine

    The main alkaloid, and the one studied for growth factors. Cleared mainly by a liver enzyme called CYP2D6, which matters for some medicines.

  • Noribogaine

    Made from ibogaine by the liver, and long-lasting. In cell tests it activates the kappa opioid receptor, the receptor linked to myelin repair in mice.

  • Ibogamine, ibogaline and others

    Present in the whole root bark, less studied. One reason a ceremony with the root is not the same as a pill of ibogaine.

A nerve fibre, in motion

What MS does to the coating of a nerve, and where iboga's alkaloids may act

Illustrative

Step 4 · Repair signals, in animalsThe brain has its own repair cells (gold) that can rebuild the coating. In rats, ibogaine raised the messages for growth factors; in mice, one of them was needed for repair, and drugs acting on noribogaine's kappa receptor helped it. None of this has been tested with iboga, so the new coating is drawn dashed. Two people with MS were described after ibogaine; two cases do not prove it works.

A nerve fibre, its myelin coating, MS and iboga's alkaloids A small drawing of a head shows spots in the brain and the spinal cord that the main picture zooms into. A nerve fibre wrapped in seven segments of myelin carries signal pulses that jump quickly from gap to gap. In MS, immune cells cross from the bloodstream and strip three segments of myelin; the signal crawls, weakens and stutters across the bare stretches. Iboga's alkaloids then arrive from the bloodstream: ibogaine, turned by the liver into long-lasting noribogaine. Finally, repair cells called oligodendrocyte precursors glow near the bare stretches and a faint dashed coating appears, showing what mouse studies on repair signals suggest; this has not been tested with iboga, and the signal itself does not change. A strip below shows footsteps, regular at first, then shorter and unsteady in MS, and a walking-pace bar that falls in MS; in the last step a dashed bar shows a slight improvement, as described in two reported cases, marked as not proven. A conceptual animation, not a scan or a measured result. Where it happens Brain and spinal cordclose up on the right Bloodstream Nerve fibreaxon Protective coatingmyelin Immune cellsT cells Iboga's alkaloidsibogaine, then noribogaine Repair cellsoligodendrocyte precursors Repair signals, in animalswhat mouse studies on repair signals suggest;not tested with iboga What the person noticesSteady walking, clear sensation Walking pace and energyDashed: two reported cases, not proven
  • A nerve signal, travelling along the fibre
  • Myelin, the nerve's protective coating
  • An immune cell that strips the coating
  • An iboga alkaloid molecule
  • Golden glow: a repair cell, as in mouse studies
  • Dashed: possible new coating, not tested with iboga
A conceptual sequence, not a brain scan, a measured human response or a treatment result. The repair findings come from research in rats and mice; the only human evidence is a report of two cases. Read the case report ↗

The science in plain words

Why researchers are looking at iboga for MS

None of what follows proves that iboga treats MS. No one has tested ibogaine in an animal model of MS, and there is no clinical trial. It explains why the question is being asked, and why we describe it as theory.

The brain repairs its myelin best early on; with time, repair slows and fails in many old lesions. That is why we favour people whose MS is stable and at an early stage.

Read it honestly

What we do not know yet

If you read elsewhere that a clinic "reverses" MS or "regrows myelin", ask for the published data. We would rather tell you less and be right. See iboga vs ibogaine and how iboga works.

Who can come

Stable or early MS strongly recommended. Every file reviewed by our medical team.

MS changes the medical picture: the heart, balance, heat, the bladder and several MS medicines all matter for iboga. Our physician reviews every application before anything is confirmed, and decides with you whether and how a retreat can be planned. Sometimes the answer is no, or not yet, and we will say so plainly.

Never stop or pause a disease-modifying treatment on your own. Stopping fingolimod, for example, can cause a severe rebound of MS activity, sometimes worse than before treatment. Our physician plans with you and your neurologist; sometimes the safe answer is to keep your treatment and change the plan, or to wait.

These requests help us prepare; they are not medical promises. The physician's review decides how the retreat is planned for you. More on preparation and the medical protocol.

For partners, sons and daughters

If you are reading this for someone you love

Many of the people who first contact us about MS are a partner or a grown child of the person who lives with it. You are welcome on every step: on the discovery call, in gathering the records, and on the trip itself as their companion. The decision stays theirs, and the medical review is the same for everyone.

  1. Book a call together

    Ask every question, side by side. Book a discovery call.

  2. Gather the records

    The neurologist's letter, the latest MRI report, the medication list and a recent ECG.

  3. Apply, and wait for the medical review

    Our physician reads the file and tells you plainly whether a retreat is safe to plan.

Who holds it

Practitioners for the ceremony, a physician and a psychologist for the body and mind

Practitioners initiated in Gabon hold the ceremony. Our physician and psychologist hold the body and the mind, and Lisa is your one contact from first call to flight home. Meet everyone on the team page.

  • Michael Cassidy Mboma
    Michael Cassidy MbomaMissoko Bwiti practitioner. Sets and paces every dose, and guides each guest through the life review during the night.
  • Dr Paola Villarreal
    Dr Paola VillarrealPhysician. Reviews your records and medicines, clears you, runs the cardiac protocol.
  • Tania
    TaniaPsychologist. Preparation, integration, four calls over the three months after you fly home.

Your stay

From the first call to three months after

  1. Before

    Medical review of your file, your neurologist's letter and MRI report, an ECG and bloodwork, a plan for your medicines, and a call with the psychologist.

  2. The ceremony nights

    The root is given in steps, the practitioner watching you before giving more, the physician in the room all night. See the ceremony.

  3. Processing and integration days

    Rest out of the heat, gentle movement at your own pace, talking through the night's life review, time in nature at the cenote.

  4. Three months after

    Four integration calls over three months, specialist follow-up at one and three months, and a summary for your neurologist if you want one. Your MS treatment, exercise and usual care carry on: they remain the best-proven way to live well with MS.

Dates

Next retreats

Ten or fourteen days on the neurological program, from the same arrival date, eight guests each; full list on the schedule. Apply early: the medical review of an MS file can take a little longer.

The neurological program

A specialist team built around your condition

Parkinson's, Alzheimer's and multiple sclerosis each need more than a standard retreat. On the neurological program, specialists in your condition join our physician before you travel, while you are with us and after you go home, and they work with your own neurologist. Ten or fourteen days, in a private room, so there is time to settle, adjust and be observed.

Neurological program · US dollars, per person

  • 10 days$11,500three ceremonies · private room
  • 14 days$15,900three or four ceremonies · private room

Everything in our standard program, plus the specialists and care listed here. The $500 deposit is refunded in full if our medical team cannot clear you.

  • Specialist review before you travelYour records and medicines read by a specialist in your condition, then a video consultation with you and your family.
  • A night nurse on ceremony nightsOne-to-one, at your bedside, on top of the physician on site around the clock.
  • Assessments before and afterMovement, memory or walking measured on arrival and before you leave, in a report for your neurologist.
  • Your medicines, kept on scheduleTimed doses, swallowing and balance checked daily; nothing is stopped without your doctors.
  • A companion welcomeA family member can stay with you; ask on your call for the companion rate.
  1. BeforeRecords, medicines, a video callThe specialist and our physician agree on your plan with your neurologist.
  2. At the centerWatched day and nightBaseline tests, daily checks, a nurse at your side during each ceremony.
  3. AfterFollow-up at one and three monthsThe same tests again, a written report, and the specialist on call.

With every neurological guest: our physician around the clock, a cardiologist for the ECG before and the heart monitoring during ceremonies, and our psychologist, Tania González.

Questions about MS

Straight answers

Can iboga cure MS or repair myelin?

No one can promise that, and we will not. In rats and mice, ibogaine and noribogaine touch signals linked to myelin repair, and one published report describes two people with MS after ibogaine. No one has tested ibogaine in an animal model of MS, and there is no clinical trial. It is a hypothesis, not a proven treatment.

Should I stop my MS treatment before coming?

Never on your own. Disease-modifying treatments reduce relapses and new lesions, and stopping some of them, fingolimod in particular, can bring a severe rebound. Declare every medicine on your health form; our physician decides with you and your neurologist what continues and how the retreat is timed around it.

I take fingolimod or another S1P modulator. Can I come?

Possibly not, and it needs careful review. Fingolimod, siponimod, ozanimod and ponesimod slow the heart, and ibogaine does too. They also cannot simply be paused. Our physician will ask for a cardiology review and your neurologist's view, and may decline; if so, we explain why.

Why do you recommend stable or early MS?

For safety first: balance, the bladder, swallowing and medicines are usually simpler early on, and a recent relapse adds risk. And for the science: the brain repairs myelin best early, and repair fails in many old lesions. People with progressive MS can apply; in the one published report, the woman with progressive MS had more stiffness during treatment, and our medical team reviews these files with extra care.

Is the heat in Cancún a problem?

It can be. Many people with MS feel their symptoms flare for a while when they get warm. Tell us how heat affects you; the team plans cool rest, shade and fluids, and watches for fever.

My balance is poor. How is the night planned?

Iboga makes everyone unsteady for a day or two, so you stay lying down during the ceremony, and someone helps you every time you need to stand or go to the bathroom. Your room is prepared for safe movement, and the team stays with you through the night and the next day.

What if the medical team says no?

Then your deposit is refunded in full, and we tell you why. Sometimes the answer is a later date, after a stable period, a medicine plan or more tests.

Sources

The research behind this page

  1. Chen DQ, Inzunza Domínguez JA, Valle Uzeta JM, Pushparaj AP, Dickinson JE. Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis. Frontiers in Immunology 2025;16:1535782. Read ↗
  2. Marton S, González B, Rodríguez-Bottero S, et al. Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits. Frontiers in Pharmacology 2019;10:193. Read ↗
  3. Fulmer CG, VonDran MW, Stillman AA, et al. Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. Journal of Neuroscience 2014;34(24):8186-8196. Read ↗
  4. Güner F, Rothhammer V. Neurotrophic factors in multiple sclerosis. Frontiers in Immunology 2025;16:1654603. Read ↗
  5. Maillet EL, Milon N, Heghinian MD, et al. Noribogaine is a G-protein biased κ-opioid receptor agonist. Neuropharmacology 2015;99:675-688. Read ↗
  6. Du C, Duan Y, Wei W, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nature Communications 2016;7:11120. Read ↗
  7. Govender D, Moloko L, Papathanasopoulos M, et al. Ibogaine administration following repeated morphine administration upregulates myelination markers CNP and MBP mRNA and protein expression in the internal capsule of Sprague Dawley rats. Frontiers in Neuroscience 2024;18:1378841. Read ↗
  8. Obach RS, Pablo J, Mash DC. Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. Drug Metabolism and Disposition 1998;26(8):764-768. Read ↗
  9. Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. New England Journal of Medicine 2018;378(2):169-180. Read ↗
  10. Franklin RJM, ffrench-Constant C. Regenerating CNS myelin: from mechanisms to experimental medicines. Nature Reviews Neuroscience 2017;18(12):753-769. Read ↗
  11. Boeschoten RE, Braamse AMJ, Beekman ATF, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. Journal of the Neurological Sciences 2017;372:331-341. Read ↗
  12. Manjaly ZM, Harrison NA, Critchley HD, et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2019;90(6):642-651. Read ↗
  13. Knuijver T, Schellekens A, Belgers M, et al. Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study. Addiction 2022;117(1):118-128. Read ↗
  14. Coyle PK, Freedman MS, Cohen BA, Cree BAC, et al. Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review. Annals of Clinical and Translational Neurology 2024;11(4):842-855. Read ↗
  15. McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA 2021;325(8):765-779. Read ↗
  16. Acorda Therapeutics. Ampyra (dalfampridine) US prescribing information: seizures. Read ↗
  17. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328(7442):731. Read ↗

Bring back your inner fire

You've carried this long enough. Start with a conversation with our medical team.

Free guide, PDF

The Bwiti Life guide

  • Who holds your ceremony
  • The tradition and the medicine
  • What the research shows
  • How to prepare, day by day
This package is for
Program length